Betta Pharmaceuticals Co., Ltd
20Patents
20Active
20Granted
50Portfolio score
Filing activity: May 17, 2010 → Aug 29, 2022 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8951959B2 | Glucagon-like peptide-1 analogues and uses thereof | Human Necessities | 6 | Active |
| US9242991B2 | Substituted fused heterocycles as c-Met tyrosine kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8742138B2 | Compounds as hypoxia mimetics, and compositions and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11365196B2 | FGFR inhibitor and application thereof | Chemistry; Metallurgy | 1 | Active |
| US11053238B2 | Benzimidazole derivatives, preparation methods and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10059688B2 | Protein tyrosine kinase modulators and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11466013B2 | ERK inhibitor and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12187713B2 | Immunomodulators, compositions and methods thereof | Chemistry; Metallurgy | 0 | Active |
| US9688687B2 | Polymorphic forms of icotinib phosphate and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9409900B2 | Compound for increasing kinase active and application thereof | Chemistry; Metallurgy | 0 | Active |
| US9617257B2 | Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9085588B2 | Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof | Chemistry; Metallurgy | 0 | Active |
| US9505774B2 | Polymorphic forms of icotinib maleate and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9487570B2 | Glucagon like peptide analogs, composition, and method of use | Human Necessities | 0 | Active |
| US9611272B2 | Polymorphic forms of icotinib and uses thereof | Human Necessities | 0 | Active |
| US11466034B2 | Compound functioning as bromodomain protein inhibitor, and composition | Chemistry; Metallurgy | 0 | Active |
| US12043622B2 | Crystal form of compound for inhibiting the activity of CDK4/6 and use thereof | Chemistry; Metallurgy | 0 | Active |
| US9783524B2 | Protein tyrosine kinase modulators and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10577364B2 | Crystalline form of fused pyridine derivative's maleate and uses thereof | Performing Operations; Transporting | 0 | Active |
| US11845762B2 | Compound functioning as bromodomain protein inhibitor, and composition | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.